Pharmaceutical Executive March 31, 2022

Continued push for latest technology in biopharma will advance collection of patient data.

By unbundling technology infrastructure and governance (through a protocol layer like blockchain), Web3 promises to usher in a shift away from tech monopolies and a winner-takes-all competitive landscape. I expect these developments to fuel innovation and efficiency in data sharing across industries, including healthcare. However, impediments to data sharing in healthcare remain stubbornly in place, hindering meaningful innovation today.

That said, it’s worth considering what Web3 can offer all players in the healthcare industry and exploring how close we are to seeing the full benefits of Web3-powered healthcare data decentralization. For biopharma companies, the rise of Web3 can help them gain more granular insights into patient journeys...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Blockchain, Pharma, Pharma / Biotech, Technology
GSK Wagers $80M on a Tech Platform and Parkinson’s Drug from Flagship-Founded Vesalius
Halozyme Makes Unsolicited €2B Takeover Bid for Drug R&D Services Firm Evotec
An Update on Therapeutics for COVID-19
The Pharmacy Model Is Changing
Life Sciences: Transforming Batch Management With Innovative Tech

Share This Article